Patient experience of taking adjuvant endocrine therapy for breast cancer: a tough pill to swallow

Adjuvant endocrine therapy (AET) has substantially improved the mortality rate among breast cancer survivors. Despite the proven efficacy, the non-adherence rate to therapy is still high. This study is aimed to examine women’s challenges related to AET adherence and management. Semi-structured inter...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kuang-Yi Wen, Rita Smith, Aruna Padmanabhan, Lori Goldstein
Formato:	article
Lenguaje:	EN
Publicado:	The Beryl Institute 2017
Materias:	breast cancer survivorship experience medication adherence adjuvant therapy qualitative interview perceptions Medicine (General) R5-920 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/08cfa217076246489e904630880359b2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:08cfa217076246489e904630880359b2
record_format	dspace
spelling	oai:doaj.org-article:08cfa217076246489e904630880359b22021-11-15T04:22:14ZPatient experience of taking adjuvant endocrine therapy for breast cancer: a tough pill to swallow2372-0247https://doaj.org/article/08cfa217076246489e904630880359b22017-11-01T00:00:00Zhttps://pxjournal.org/journal/vol4/iss3/16https://doaj.org/toc/2372-0247Adjuvant endocrine therapy (AET) has substantially improved the mortality rate among breast cancer survivors. Despite the proven efficacy, the non-adherence rate to therapy is still high. This study is aimed to examine women’s challenges related to AET adherence and management. Semi-structured interviews were conducted with six Caucasian and six African American breast cancer survivors who were prescribed for AET. The transcripts of audio-taped interviews were qualitatively analyzed. Key themes were: 1) positive beliefs in AET, 2) uncertainty about long-term adherence, 3) experiences with side effects, 4) forgetting and remembering, 5) other concerns and information needs, 6) potential intervention format, and 7) culturally-coping among African American women. The findings provided insight into women’s experiences and beliefs and how these behaviors might influence AET adherence. Although most women in this study took AET as prescribed, many experienced a range of side effects and emotional distress, often without seeking support or help. New models of programs to promote adherence, support symptom management, and ultimately improve survival are critically needed. Developing culturally sensitive interventions for African American women is desirable.Kuang-Yi WenRita SmithAruna PadmanabhanLori GoldsteinThe Beryl Institutearticlebreast cancer survivorship experiencemedication adherenceadjuvant therapyqualitative interviewperceptionsMedicine (General)R5-920Public aspects of medicineRA1-1270ENPatient Experience Journal (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	breast cancer survivorship experience medication adherence adjuvant therapy qualitative interview perceptions Medicine (General) R5-920 Public aspects of medicine RA1-1270
spellingShingle	breast cancer survivorship experience medication adherence adjuvant therapy qualitative interview perceptions Medicine (General) R5-920 Public aspects of medicine RA1-1270 Kuang-Yi Wen Rita Smith Aruna Padmanabhan Lori Goldstein Patient experience of taking adjuvant endocrine therapy for breast cancer: a tough pill to swallow
description	Adjuvant endocrine therapy (AET) has substantially improved the mortality rate among breast cancer survivors. Despite the proven efficacy, the non-adherence rate to therapy is still high. This study is aimed to examine women’s challenges related to AET adherence and management. Semi-structured interviews were conducted with six Caucasian and six African American breast cancer survivors who were prescribed for AET. The transcripts of audio-taped interviews were qualitatively analyzed. Key themes were: 1) positive beliefs in AET, 2) uncertainty about long-term adherence, 3) experiences with side effects, 4) forgetting and remembering, 5) other concerns and information needs, 6) potential intervention format, and 7) culturally-coping among African American women. The findings provided insight into women’s experiences and beliefs and how these behaviors might influence AET adherence. Although most women in this study took AET as prescribed, many experienced a range of side effects and emotional distress, often without seeking support or help. New models of programs to promote adherence, support symptom management, and ultimately improve survival are critically needed. Developing culturally sensitive interventions for African American women is desirable.
format	article
author	Kuang-Yi Wen Rita Smith Aruna Padmanabhan Lori Goldstein
author_facet	Kuang-Yi Wen Rita Smith Aruna Padmanabhan Lori Goldstein
author_sort	Kuang-Yi Wen
title	Patient experience of taking adjuvant endocrine therapy for breast cancer: a tough pill to swallow
title_short	Patient experience of taking adjuvant endocrine therapy for breast cancer: a tough pill to swallow
title_full	Patient experience of taking adjuvant endocrine therapy for breast cancer: a tough pill to swallow
title_fullStr	Patient experience of taking adjuvant endocrine therapy for breast cancer: a tough pill to swallow
title_full_unstemmed	Patient experience of taking adjuvant endocrine therapy for breast cancer: a tough pill to swallow
title_sort	patient experience of taking adjuvant endocrine therapy for breast cancer: a tough pill to swallow
publisher	The Beryl Institute
publishDate	2017
url	https://doaj.org/article/08cfa217076246489e904630880359b2
work_keys_str_mv	AT kuangyiwen patientexperienceoftakingadjuvantendocrinetherapyforbreastcanceratoughpilltoswallow AT ritasmith patientexperienceoftakingadjuvantendocrinetherapyforbreastcanceratoughpilltoswallow AT arunapadmanabhan patientexperienceoftakingadjuvantendocrinetherapyforbreastcanceratoughpilltoswallow AT lorigoldstein patientexperienceoftakingadjuvantendocrinetherapyforbreastcanceratoughpilltoswallow
_version_	1718428846420656128

Patient experience of taking adjuvant endocrine therapy for breast cancer: a tough pill to swallow

Ejemplares similares